Tuesday, May 14, 2024
HomeTagsAccelerate Programs

Accelerate Programs

Orna Therapeutics Raises $221 Million Series B Financing to Advance Circular RNA Platform

Orna Therapeutics, a biotechnology company pioneering a new class of fully engineered circular RNA therapies (oRNA), announced the initial closing of its $221 million...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics